Cargando…
AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning
BACKGROUND: Rare tumors are diagnostic challenges for pathologists. Thymic epithelial tumors (TETs) are heterogenous and their treatment strategies vary according to histological subgroup. Previous work has shown that a second pathological opinion may result in a change in diagnosis for more than ha...
Autores principales: | Dolezal, James M., Guo, Wenji, Bestvina, Christine, Vokes, Everett, Donington, Jessica, Husain, Aliya, Garassino, Marina Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792820/ http://dx.doi.org/10.21037/med-22-ab012 |
Ejemplares similares
-
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
por: Cameron, Robert B., et al.
Publicado: (2023) -
Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes
por: Yang, Jun, et al.
Publicado: (2023) -
AB012. Brachytherapy for localized prostate cancer
por: Xu, Yong, et al.
Publicado: (2016) -
AB012. Update on treatments for premature ejaculation
por: Hyun, Jae-Seog
Publicado: (2017) -
Bridging over troubled waters: the doubling time and histological subtypes of thymic epithelial tumors
por: Kashima, Jumpei, et al.
Publicado: (2020)